Fellowships And Training

Globalization And Health Equity Seminar (PPS 264S)

This graduate-level course examines the forces of globalization and health, in particular how disease-causing pathogens, the knowledge to care and cure these maladies, and the products to treat them do or do not cross borders. Do the forces of globalization promise all people a fair shake for a healthy future or just a future of widening health disparity? The course investigates what approaches can help bridge these disparities, including the emergence of public-private partnerships, efforts to chart a fairer course for intellectual property rights and innovation, and the measure of health inequities in hopes of holding stakeholders accountable.

Global Health Fellows Program

Designed to equip students to join in the fight against HIV/AIDS, tuberculosis, malaria, and other pressing health challenges posed by globalization, the Global Health Fellows Program provides students with both an academic and experiential perspective on how inter-governmental institutions, public-private partnerships, and non-governmental organizations shape global health policy. The highly competitive program places graduate students from diverse fields into summer policy internships in Geneva. All Global Health Fellows participate in an intensive, week-long course, co-organized with the WHO’s Program on Trade, Foreign Policy, Diplomacy and Health, and a series of site visits to key institutions in global health throughout Geneva.

You can read more about the program, including application information, here: http://www.pubpol.duke.edu/graduate/mpp/geneva/health.php

Pharmaceutical Policy Leaders In Medicine Program

The Program organized the inaugural Pharmaceutical Policy Leaders in Medicine Institute with the American Medical Student Association Foundation in September 2007. The first four-day Institute focused on educating physicians-in-training to become the profession’s change agents and stewards for pharmaceutical policy. The objectives included evaluating claims and concerns over innovation and generic drug competition; critically appraising the promotional approaches for drugs; recognizing potential influences over prescriber choice and behavior and sources of conflict of interest; and considering strategies for improving pharmaceutical policy as well as physician prescribing practices.